Introduction {#s1}
============

Lapatinib is a small molecular drug that has been shown to be a dual tyrosine kinase inhibitor, which is involved in the EGFR/HER1 and ERBB2/HER2 pathways and suppresses the autophosphorylation of these receptors. Clinically, it has been used in combination therapy with capecitabine in patients with advanced or metastatic breast cancer that overexpressed ERBB2/HER2 in the cases of previous treatment with anthracyclines, taxanes, or trastuzumab (Herceptin) (Geyer et al., [@B9]). In addition, a satisfactory response rate has also been found with Lapatinib treatment for ERBB2-positive progressive gastric cancer (Cetin et al., [@B5]; Satoh et al., [@B34]). However, in patients with head and neck squamous cell carcinoma, Lapatinib combined with radiotherapy did not show therapeutic effects (Harrington et al., [@B12]). Similarly, in ERBB2/EGFR positive metastatic bladder cancer patients who underwent first-line chemotherapy didn\'t get benefit from Lapatinib maintenance treatment (Powles et al., [@B29]). Therefore, uncovering the drug-resistant mechanism of Lapatinib will help improve the therapeutic effects of Lapatinib targeted therapy and find new sensitive biomarkers.

Long non-coding RNAs (lncRNAs) are a large class of transcribed RNA molecules that are longer than 200 nucleotides but do not encode proteins. In addition to the regulation of diverse cellular processes, such as epigenetics, cell cycle, and cell differentiation, they have been found to play important roles in carcinogenesis, tumor development, and treatment resistance (Heery et al., [@B14]; Peng et al., [@B28]; Hahne and Valeri, [@B10]; Wang et al., [@B39]; Wu et al., [@B41]). For instance, Ma et al. found that lncRNAs CASC9 and EWAST1 were two crucial molecules associated to EGFR-TKIs resistant in non-small cell lung cancer (Ma et al., [@B25]).

The Cancer Cell Line Encyclopedia (CCLE) database (<https://portals.broadinstitute.org/ccle>) is an open access resource with the most completely integrated datasets of cancer cells genomes and drug effectiveness. It includes the experimental datasets of drug treatment of 24 kinds of chemical compounds in almost 1,000 cancer cell lines of various human cancers (Barretina et al., [@B3]). Kim et al. used CCLE database in their recent publication. They found that high levels of FGFR and integrin β3 are resistant to crizotinib treatment, suggesting that FGFR, and integrin β3 could be predictive markers for Met-targeted therapy (Kim et al., [@B17]). To date, there is a limited number of studies (Jiang et al., [@B15]; Niknafs et al., [@B26]; Bester et al., [@B4]; Li D. et al., [@B19]; Sun et al., [@B37]) to explore lncRNAs by CCLE database. In this study, we analyzed the lncRNAs of whole-genome datasets of CCLE after treatment with Lapatinib on pan-cancer cell lines, and proposed crucial lncRNAs GIHCG and SPINT1-AS1 involved in regulating Lapatinib sensitivity.

Materials and Methods {#s2}
=====================

Data Extraction From CCLE
-------------------------

There are 5,344 lncRNA probes and 49,331 non-lncRNA probes in the whole-genome gene expression profile chip used in CCLE (Barretina et al., [@B3]). There are 1,037 cell lines of various cancer types in the database. Among those, 504 cell lines had been treated with Lapatinib and got IC50 (half maximal inhibitory concentration) data and 501 cell lines were examined by microarrays. Since the study focused on solid tumors, we deleted cell lines of hematopoietic and lymphoid cell lines. Finally, 420 solid tumor cell lines were enrolled in the study ([Table 1](#T1){ref-type="table"}).

###### 

The distribution of 420 cancer cell lines of solid tumor.

  **Cancer types**            **Count**
  --------------------------- -----------
  Autonomic ganglia           10
  Biliary tract               1
  Bone                        11
  Breast                      29
  Central nervous system      29
  Endometrium                 20
  Kidney                      9
  Large intestine             23
  Liver                       19
  Lung                        91
  Esophagus                   15
  Ovary                       28
  Pancreas                    28
  Pleura                      7
  Prostate                    3
  Salivary gland              1
  Skin                        40
  Soft tissue                 12
  Stomach                     18
  Thyroid                     5
  Upper aerodigestive tract   7
  Urinary tract               14

Cancer Cell Lines and Cell Culture
----------------------------------

Nineteen cancer cell lines were used for validating experiments *in vitro*. Four of those were gastric cancer cell lines (NCI-N87, SGC-7901, AGS, and MKN-45), three were melanoma cell lines (MuM-2C, MV3, and A-375), three were hepatocarcinoma cell lines (LM3, 97L, and Huh7), three were thyroid cancer cell lines (KHM-5M, CAL-62, and C643), two were breast cancer cell lines (MCF7 and SK-BR-3), two were pancreatic cancer cell lines (TCC-PAN2 and BxPC3), and two were colorectal cancer lines (DLD-1 and NCIH-747). Cell lines NCI-N87, MuM-2C, LM3, MV3, Huh7, SGC-7901, CAL-62, AGS, MCF7, C643, 97L, SK-BR-3, KHM-5M, A-375, TCC-PAN2, MKN-45, and BxPC3 were purchased from the Cell Bank of Type Culture Collection of Chinese Academy of Sciences (Shanghai, China). Cell lines DLD-1 and NCIH-747 were purchased from The Global Bioresource Center ATCC (Maryland, USA). The cell lines were cultured in RPMI-1640 supplemented with 10% fetal bovine serum in a humidified incubator at 37°C with 95% air and 5% CO2.

Transient Transfection of siRNAs
--------------------------------

SPINT1-AS1 and GIHCG siRNAs were transfected into cancer cells by Lipofectamine 2000 (Invitrogen, Carlsbad, California, USA) according to the manufacturer\'s instructions. The siRNA sequences are shown in Table S1.

RNA Extraction and Quantitative Real-Time PCR Analysis
------------------------------------------------------

Total RNA was isolated using the TRIzol solution (Invitrogen, California, USA). The cDNA was synthesized using Reverse Transcription kit (TOYOBO, Japan). Real-time PCR was performed in 10 μl reaction mixtures with the HT 7900 (Applied Biosystems, Foster City, USA) using SYBR™ Select Master Mix (Applied Biosystems, Foster City, USA). The sequences of primers were designed and synthesized by Sunny Biotech (Shanghai, China): The primer sequences are shown in Table S1.

Cell Viability Assay
--------------------

Five thousand cells of different cancers were placed in each well of 96-well plates (100 μl/well). Different concentrations of Lapatinib (Selleck, Houston, USA) were incubated for 48 h. After adding 10 μl CCK-8 for 2 h, OD value was measured at 450 nm by spectrophotometry (BioTek, Vermont, USA).

Data Analysis
-------------

The "corrplot" and "pheatmap" package in R software were utilized for visualizing pearson correlation analysis and cluster analysis by "euclidean" method. The Benjamini and Hochberg method was used to calculate P. adjust value. By means of "clusterProfiler" package in R, GSEA (Gene Set Enrichment Analysis) and GO (Gene Ontology) analyses were carried out to explore involved gene clusters. GSEA is a computational method based on previous publication by Subramanian et al. ([@B35]). GO analysis is a kind of gene enrichment analysis to classify gene set on three aspects: molecular function, cellular component and biological process (Ashburner et al., [@B1]). Differentially expressed lncRNAs and genes with difference larger than 1.5-fold were obtained by "limma" package, which is often used to explore differentially expressed genes between two phenotypes (Ritchie et al., [@B30]). The top 10 gene clusters of all cancer cell lines were scored using "GSVA" package (*G*ene *S*et *V*ariation *A*nalysis,) in R language, which utilizes non-parametric unsupervised method for evaluating gene set enrichment (GSE) in transcriptomic data (Hanzelmann et al., [@B11]). Cytoscape software was applied to establish co-expression network and determine hub lncRNAs. The inhibiting ratio and Lapatinib IC50 were calculated according to OD value by GraphPad Prism 6.0 (Inc., La Jolla, CA, USA). The relative RNA levels were calculated by 2^−ΔΔCT^ (ΔCT = LncRNA^CTvalue^ − GAPDH^CTvalue^, ΔΔCT = ΔCT−ΔCT^min^, ΔCT^min^: minimum ΔCT of expression levels of lncRNA GIHCG or SPINT1-AS1 in cell line). Student\'s *t*-tests were performed by GraphPad Prism 6.0. *P* \< 0.05 was considered statistically significant.

Results {#s3}
=======

Lapatinib IC50 From Pan-Cancer Cell Lines Analysis
--------------------------------------------------

The CCLE data of Lapatinib IC50 of the selected 420 cell lines was shown in [Table 2](#T2){ref-type="table"}. The upper limit of IC50 was originally determined as 8 μM for those cancer cell lines in the database. There were 302 cancer cell lines with IC50 higher than 8 μM, which were insensitive to Lapatinib drug. There were 118 cancer cell lines with IC50 lower than 8 μM, which were relatively sensitive to Lapatinib drug. Taking 8 μM of IC50 as a threshold, we categorized 420 cancer cell lines into two groups, high_IC50 (*n* = 302) and low_IC50 (*n* = 118). Since EGFR and ERBB2 are the targets of the Lapatinib drug, the expression levels of EGFR, and ERBB2 in high_IC50 and low_IC50 groups were analyzed. The expression levels of EGFR and ERBB2 were significantly higher in low-IC50 group than in high_IC50 ([Figure 1A](#F1){ref-type="fig"}, *P* = 0.006 and *P* \< 0.001, respectively). The distribution tendency of 22 types of solid cancer cell lines in high-IC50 (up to 8 μM) and low_IC50 (lower than 8 μM) groups is presented in [Figure 1B](#F1){ref-type="fig"}. GSEA analysis showed that ERBB pathway-related genes were enriched in low_IC50 group ([Figure 1C](#F1){ref-type="fig"}, ERBB signaling pathway NES = −1.81, *P* \< 0.002, p. adjust = 0.064; regulation of ERBB signaling pathway NES = −1.69, *P* \< 0.002, p. adjust = 0.064).

###### 

Lapatinib IC50 of 420 cancer cell lines.

  **CCLE cell line names**   **Cell type**               **IC50 (μM)[^\*^](#TN1){ref-type="table-fn"}**
  -------------------------- --------------------------- ------------------------------------------------
  SNU1                       Stomach                     8
  KMRC2                      Kidney                      8
  HEYA8                      Ovary                       8
  NCIH1915                   Lung                        8
  SH10TC                     Stomach                     8
  JMSU1                      Urinary tract               8
  UACC62                     Skin                        8
  SKLU1                      Lung                        8
  ES2                        Ovary                       8
  SNU398                     Liver                       8
  MSTO211H                   Pleura                      8
  HMC18                      Breast                      8
  HS229T                     Lung                        8
  HS895T                     Skin                        8
  NCIH1092                   Lung                        8
  8505C                      Thyroid                     8
  RKO                        Large intestine             8
  SW1573                     Lung                        8
  NCIH2172                   Lung                        8
  IGR37                      Skin                        8
  T24                        Urinary tract               8
  NCIH1581                   Lung                        8
  HLF                        Liver                       8
  MG63                       Bone                        8
  HS840T                     Upper aerodigestive tract   8
  DMS114                     Lung                        8
  HS936T                     Skin                        8
  FU97                       Stomach                     8
  NCIH2052                   Pleura                      8
  8305C                      Thyroid                     8
  RERFLCAI                   Lung                        8
  SW579                      Thyroid                     8
  TOV112D                    Ovary                       8
  HS729                      Soft tissue                 8
  KMRC1                      Kidney                      8
  SJSA1                      Bone                        8
  HUH1                       Liver                       8
  1321N1                     Central nervous system      8
  TC71                       Bone                        8
  KELLY                      Autonomic ganglia           8
  NCIH520                    Lung                        8
  IGR39                      Skin                        8
  EN                         Endometrium                 8
  U118MG                     Central nervous system      8
  639V                       Urinary tract               8
  HGC27                      Stomach                     8
  UMUC3                      Urinary tract               8
  42MGBA                     Central nervous system      8
  SKNBE2                     Autonomic ganglia           8
  CALU1                      Lung                        8
  NCIH211                    Lung                        8
  HEC59                      Endometrium                 8
  BFTC909                    Kidney                      8
  RPMI7951                   Skin                        8
  IPC298                     Skin                        8
  NCIH1651                   Lung                        8
  MDAMB436                   Breast                      8
  SKNDZ                      Autonomic ganglia           8
  DKMG                       Central nervous system      8
  IALM                       Lung                        8
  NCIH1792                   Lung                        8
  JHH6                       Liver                       8
  PSN1                       Pancreas                    8
  HOS                        Bone                        8
  CAL78                      Bone                        8
  U87MG                      Central nervous system      8
  GI1                        Central nervous system      8
  NCIH1155                   Lung                        8
  SBC5                       Lung                        8
  IMR32                      Autonomic ganglia           8
  NCIH460                    Lung                        8
  WM2664                     Skin                        8
  MEWO                       Skin                        8
  BT549                      Breast                      8
  SKMEL30                    Skin                        8
  NCIH1703                   Lung                        8
  HEP3B217                   Liver                       8
  TT2609C02                  Thyroid                     8
  HEPG2                      Liver                       8
  SKNAS                      Autonomic ganglia           8
  NCIH1944                   Lung                        8
  SW1271                     Lung                        8
  COLO679                    Skin                        8
  DAOY                       Central nervous system      8
  SHP77                      Lung                        8
  NCIH1299                   Lung                        8
  VMRCRCZ                    Kidney                      8
  LOXIMVI                    Skin                        8
  NCIH1339                   Lung                        8
  HS746T                     Stomach                     8
  SKHEP1                     Liver                       8
  NCIH1694                   Lung                        8
  COV504                     Ovary                       8
  NCIH1793                   Lung                        8
  SNU423                     Liver                       8
  JHUEM2                     Endometrium                 8
  CALU6                      Lung                        8
  J82                        Urinary tract               8
  UACC257                    Skin                        8
  G402                       Soft tissue                 8
  MESSA                      Soft tissue                 8
  HT1080                     Soft tissue                 8
  MPP89                      Pleura                      8
  OVTOKO                     Ovary                       8
  SUIT2                      Pancreas                    8
  SIMA                       Autonomic ganglia           8
  H4                         Central nervous system      8
  WM1799                     Skin                        8
  A673                       Bone                        8
  NCIH1975                   Lung                        8
  MDAMB157                   Breast                      8
  SKMEL5                     Skin                        8
  SKES1                      Bone                        8
  NCIH2452                   Pleura                      8
  NCIH647                    Lung                        8
  SAOS2                      Bone                        8
  NCIH2023                   Lung                        8
  NCIH226                    Lung                        8
  SF295                      Central nervous system      8
  SW620                      Large intestine             8
  NCIH661                    Lung                        8
  HS939T                     Skin                        8
  HS578T                     Breast                      8
  HCC44                      Lung                        8
  EFO21                      Ovary                       8
  KPNSI9S                    Autonomic ganglia           8
  SF126                      Central nervous system      8
  HS739T                     Breast                      8
  NCIH1693                   Lung                        8
  TOV21G                     Ovary                       8
  KALS1                      Central nervous system      8
  A375                       Skin                        8
  CHP212                     Autonomic ganglia           8
  SW1990                     Pancreas                    8
  LOUNH91                    Lung                        8
  OV90                       Ovary                       8
  SKMEL2                     Skin                        8
  NCIH23                     Lung                        8
  YKG1                       Central nervous system      8
  WM88                       Skin                        8
  ACHN                       Kidney                      8
  SKNFI                      Autonomic ganglia           8
  DU145                      Prostate                    8
  GAMG                       Central nervous system      8
  MDAMB435S                  Skin                        8
  NCIH2087                   Lung                        8
  NCIH1563                   Lung                        8
  HEC6                       Endometrium                 8
  NCIH2228                   Lung                        8
  SW1353                     Bone                        8
  RD                         Soft tissue                 8
  SNU387                     Liver                       8
  OC316                      Ovary                       8
  SKNSH                      Autonomic ganglia           8
  FUOV1                      Ovary                       8
  LCLC103H                   Lung                        8
  HCC15                      Lung                        8
  KNS60                      Central nervous system      8
  PK45H                      Pancreas                    8
  HT1197                     Urinary tract               8
  KP4                        Pancreas                    8
  GB1                        Central nervous system      8
  HT144                      Skin                        8
  U2OS                       Bone                        8
  HLE                        Liver                       8
  COLO741                    Skin                        8
  TCCSUP                     Urinary tract               8
  LN18                       Central nervous system      8
  NCIH810                    Lung                        8
  JHH2                       Liver                       8
  T98G                       Central nervous system      8
  QGP1                       Pancreas                    8
  IGROV1                     Ovary                       8
  LN229                      Central nervous system      8
  OVCAR4                     Ovary                       8
  JHH4                       Liver                       8
  HS944T                     Skin                        8
  BCPAP                      Thyroid                     8
  HS683                      Central nervous system      8
  NCIH2009                   Lung                        8
  GMS10                      Central nervous system      8
  G401                       Soft tissue                 8
  A172                       Central nervous system      8
  HEC1B                      Endometrium                 8
  HEC251                     Endometrium                 8
  SW900                      Lung                        8
  OC315                      Ovary                       8
  JHOS2                      Ovary                       8
  RERFLCMS                   Lung                        8
  ISTMES1                    Pleura                      8
  RVH421                     Skin                        8
  MFE296                     Endometrium                 8
  HS766T                     Pancreas                    8
  HCC78                      Lung                        8
  MKN7                       Stomach                     8
  C32                        Skin                        8
  HEC265                     Endometrium                 8
  NCIH1184                   Lung                        8
  SW480                      Large intestine             8
  NCIH522                    Lung                        8
  NCIH650                    Lung                        8
  OC314                      Ovary                       8
  COV318                     Ovary                       8
  HS852T                     Skin                        8
  NCIH727                    Lung                        8
  EFO27                      Ovary                       8
  SJRH30                     Soft tissue                 8
  KNS81                      Central nervous system      8
  SNU449                     Liver                       8
  A2058                      Skin                        8
  HS294T                     Skin                        8
  SNU182                     Liver                       8
  COLO205                    Large intestine             8
  HUCCT1                     Biliary tract               8
  ISHIKAWAHERAKLIO02ER       Endometrium                 8
  LS411N                     Large intestine             8
  PATU8902                   Pancreas                    8
  PC3                        Prostate                    8
  SKMEL24                    Skin                        8
  C3A                        Liver                       8
  AN3CA                      Endometrium                 8
  SNGM                       Endometrium                 8
  TE1                        Esophagus                   8
  NCIH1573                   Lung                        8
  HCT116                     Large intestine             8
  NCIH1568                   Lung                        8
  HPAC                       Pancreas                    8
  HEC151                     Endometrium                 8
  OVMANA                     Ovary                       8
  HCC56                      Large intestine             8
  HEC1A                      Endometrium                 8
  CAKI2                      Kidney                      8
  CAPAN2                     Pancreas                    8
  NCIH1373                   Lung                        8
  NCIH1048                   Lung                        8
  CAS1                       Central nervous system      8
  HCC1569                    Breast                      8
  SNU475                     Liver                       8
  LS123                      Large intestine             8
  NCIH1341                   Lung                        8
  PANC0403                   Pancreas                    8
  MOGGCCM                    Central nervous system      8
  IM95                       Stomach                     8
  ONCODG1                    Ovary                       8
  NCIH747                    Large intestine             8
  WM115                      Skin                        8
  DBTRG05MG                  Central nervous system      8
  EFE184                     Endometrium                 8
  HS695T                     Skin                        8
  KYM1                       Soft tissue                 8
  MORCPR                     Lung                        8
  CORL105                    Lung                        8
  PL45                       Pancreas                    8
  SQ1                        Lung                        8
  TEN                        Endometrium                 8
  T84                        Large intestine             8
  HCC1395                    Breast                      8
  ZR751                      Breast                      8
  RERFGC1B                   Stomach                     8
  DETROIT562                 Upper aerodigestive tract   8
  DV90                       Lung                        8
  SW780                      Urinary tract               8
  KYSE510                    Esophagus                   8
  SKMEL31                    Skin                        8
  NCIH1869                   Lung                        8
  NCIH441                    Lung                        8
  NCIH2085                   Lung                        8
  CORL23                     Lung                        8
  OCUM1                      Stomach                     8
  SNUC2A                     Large intestine             8
  TE5                        Esophagus                   8
  MKN45                      Stomach                     8
  KP3                        Pancreas                    8
  KNS42                      Central nervous system      8
  KLE                        Endometrium                 8
  SW1417                     Large intestine             8
  KMBC2                      Urinary tract               8
  LC1SQSF                    Lung                        8
  OVSAHO                     Ovary                       8
  VMRCLCD                    Lung                        8
  KP2                        Pancreas                    8
  BT20                       Breast                      8
  RT4                        Urinary tract               8
  EFM19                      Breast                      8
  KYSE70                     Esophagus                   8
  A253                       Salivary gland              8
  COLO201                    Large intestine             8
  SW48                       Large intestine             8
  SU8686                     Pancreas                    8
  MFE280                     Endometrium                 8
  CAMA1                      Breast                      8
  KURAMOCHI                  Ovary                       8
  COLO678                    Large intestine             8
  HUPT3                      Pancreas                    8
  HCC1187                    Breast                      8
  T47D                       Breast                      8
  MDAMB415                   Breast                      8
  HSC2                       Upper aerodigestive tract   8
  KYSE150                    Esophagus                   8
  UACC812                    Breast                      8
  ONS76                      Central nervous system      8
  KNS62                      Lung                        8
  PANC1005                   Pancreas                    7.987659
  ISTMES2                    Pleura                      7.889611
  NCIH1355                   Lung                        7.860697
  KYSE30                     Esophagus                   7.858886
  22RV1                      Prostate                    7.847305
  MIAPACA2                   Pancreas                    7.469959
  JHOS4                      Ovary                       7.408363
  A204                       Soft tissue                 7.399833
  HCC70                      Breast                      7.36332
  NCIH2286                   Lung                        7.359588
  MALME3M                    Skin                        7.325411
  GCIY                       Stomach                     7.255416
  PK1                        Pancreas                    7.236271
  786O                       Kidney                      7.178035
  T3M10                      Lung                        7.170651
  A2780                      Ovary                       7.146677
  SKLMS1                     Soft tissue                 7.136584
  HT1376                     Urinary tract               7.084046
  HUPT4                      Pancreas                    7.0557
  PANC0327                   Pancreas                    6.904092
  SW1088                     Central nervous system      6.737086
  SNU16                      Stomach                     6.697771
  PLCPRF5                    Liver                       6.669433
  HARA                       Lung                        6.656741
  MELHO                      Skin                        6.552444
  RT112                      Urinary tract               6.525924
  K029AX                     Skin                        6.444433
  EBC1                       Lung                        6.372372
  MCAS                       Ovary                       6.3241
  COLO320                    Large intestine             6.295312
  PK59                       Pancreas                    6.190494
  HT29                       Large intestine             5.884947
  TE9                        Esophagus                   5.855279
  WM983B                     Skin                        5.68912
  KCIMOH1                    Pancreas                    5.619114
  TYKNU                      Ovary                       5.343411
  8MGBA                      Central nervous system      5.22662
  PANC0203                   Pancreas                    5.197284
  NCIH1650                   Lung                        5.152449
  NIHOVCAR3                  Ovary                       5.117735
  OVCAR8                     Ovary                       5.095931
  JHH7                       Liver                       4.92477
  HMCB                       Skin                        4.767848
  MKN74                      Stomach                     4.689733
  HCT15                      Large intestine             4.666833
  WM793                      Skin                        4.641666
  BXPC3                      Pancreas                    4.599786
  HCC1806                    Breast                      4.378565
  ESS1                       Endometrium                 4.373962
  SCC9                       Upper aerodigestive tract   4.287216
  MHHES1                     Bone                        4.274786
  A549                       Lung                        4.227246
  HPAFII                     Pancreas                    4.222833
  GCT                        Soft tissue                 4.213955
  C2BBE1                     Large intestine             4.099345
  KE39                       Stomach                     4.05606
  LU99                       Lung                        3.926637
  VMRCRCW                    Kidney                      3.895097
  KYSE410                    Esophagus                   3.808475
  KYSE520                    Esophagus                   3.773011
  NCIH2030                   Lung                        3.72418
  OE33                       Esophagus                   3.538352
  HDQP1                      Breast                      3.104604
  G361                       Skin                        3.047757
  RL952                      Endometrium                 3.012983
  NCIH2122                   Lung                        2.934416
  NCIH28                     Pleura                      2.911829
  LS513                      Large intestine             2.880553
  MCF7                       Breast                      2.845194
  NCIH358                    Lung                        2.83834
  ASPC1                      Pancreas                    2.785628
  KYSE450                    Esophagus                   2.574543
  NUGC3                      Stomach                     2.410753
  SCC25                      Upper aerodigestive tract   2.398599
  SW403                      Large intestine             2.379555
  LUDLU1                     Lung                        2.319642
  MDAMB468                   Breast                      2.312559
  5637                       Urinary tract               2.307768
  PC14                       Lung                        2.149659
  L33                        Pancreas                    2.124577
  CAL12T                     Lung                        1.951666
  CAL851                     Breast                      1.899548
  HCC4006                    Lung                        1.854881
  NCIH2444                   Lung                        1.746528
  AZ521                      Stomach                     1.659918
  SCABER                     Urinary tract               1.511766
  SKMES1                     Lung                        1.476444
  HCC1954                    Breast                      1.457828
  MDAMB453                   Breast                      1.4379
  NCIH322                    Lung                        1.362128
  TE15                       Esophagus                   1.285878
  HCC2935                    Lung                        1.239924
  769P                       Kidney                      1.057461
  MFE319                     Endometrium                 1.026923
  SKOV3                      Ovary                       0.983712
  KYSE180                    Esophagus                   0.876243
  FADU                       Upper aerodigestive tract   0.823073
  SKCO1                      Large intestine             0.71562
  KYSE140                    Esophagus                   0.68893
  CAL27                      Upper aerodigestive tract   0.688771
  CHL1                       Skin                        0.675993
  TE11                       Esophagus                   0.63775
  JHH5                       Liver                       0.569108
  CALU3                      Lung                        0.494588
  MDAMB175VII                Breast                      0.468741
  NCIH1666                   Lung                        0.386496
  NCIH1648                   Lung                        0.373409
  HCC827                     Lung                        0.372134
  NCIH3255                   Lung                        0.333763
  NCIH2170                   Lung                        0.300981
  TE617T                     Soft tissue                 0.242928
  CCK81                      Large intestine             0.240195
  SKBR3                      Breast                      0.196392
  AU565                      Breast                      0.18321
  NUGC4                      Stomach                     0.171543
  ZR7530                     Breast                      0.166593
  BT474                      Breast                      0.116183
  NCIN87                     Stomach                     0.066107

*Extracted from CCLE database (<https://portals.broadinstitute.org/ccle>)*.

*IC50 (μM) is half maximal inhibitory concentration (IC50), which is defined as a drug concentration producing absolute 50% inhibition of growth in cell proliferation assay. By definition, this metric relies on the assumption, that at a high concentration of the drug, 100% effect is achieved as all cells die in a proliferation assay*.

![The correlation of mRNA expression levels of EGFR and ERBB2 and Lapatinib IC50. **(A)** The bar charts of mRNA expression levels of EGFR (left) and ERBB2 (right) of cancer cell lines between the high_IC50 and low_IC50 groups of Lapatinib drug. The expression levels of EGFR and ERBB2 are significantly higher in the low_IC50 group than that in the high_IC50 group (*p* \< 0.01). **(B)** The distribution tendency of 22 types of solid cancer cell lines in high-IC50 (up to 8 μM) and low_IC50 (lower than 8 μM). The red lines represent mean value of Lapatinib IC50. **(C)** The enrichment analysis of ERBB signaling pathway reveals that ERBB signaling pathway is significantly enriched in Lapatinib low_IC50 group. "Y" axis indicates the enrichment score (ES) value, and "X" axis indicates genes according to differential expression value between high_IC50 and low_IC50 groups. The blue and red dot curves represent ES value. The bottom barcodes represent the leading gene set that strongly contributed to ES value. The positive ES value represents positive correlation to Lapatinib IC50, and minus ES value represents negative correlation to Lapatinib IC50.](fgene-10-00025-g0001){#F1}

Pathway Analysis Involved in Lapatinib Sensitivity
--------------------------------------------------

To illustrate the mechanism of Lapatinib resistance, we selected genes with fold-change \>1.5 times to perform GO analysis (Table S2). In the top 10 involved pathways, Lapatinib sensitivity was positively associated with cell keratin, epithelial differentiation, and cell-cell junction, while negatively related to signatures of extracellular matrix ([Figure 2](#F2){ref-type="fig"}, *P* \< 0.001, *P*. adjust \< 0.001).

![The network of top 10 genes by GO pathway analysis. The large spots in the center of the networks are the gene clusters, and the small spots connected with large spots are the related genes in the pathways. Red spots indicate that the genes are highly expressed in the high_IC50 group. Green spots indicate that the genes are highly expressed in the low_IC50 group. The darker red or green spot are the larger fold-change of differential genes. The black spots with different sizes and numbers on the right side indicate the gene numbers in the gene clusters.](fgene-10-00025-g0002){#F2}

Analysis of LncRNAs Involved in Lapatinib Sensitivity
-----------------------------------------------------

We further screened the differentially expressed lncRNAs, and 44 lncRNAs were identified between the high_IC50 group and low_IC50 group ([Figure 3A](#F3){ref-type="fig"} and [Table 3](#T3){ref-type="table"}, fold-change \>1.5, *P* \< 0.01). Then, we selected genes in the top 10 pathways and 44 differential lncRNAs for the construction of the co-expression network. The enrichment scores of the top 10 pathway genes in every cancer cell lines were calculated and determined by GSVA analysis. Five lncRNAs were highlighted as the hub factors in the top 10 regulating pathways ([Figure 3B](#F3){ref-type="fig"}). The association of the 5 lncRANs with 199 genes in the top 10 pathways was further analyzed, and a molecular network of co-expression was established, which included top 50 key molecules closely associated to Lapatinib sensitivity. Three crucial lncRNAs, GIHCG, SPINT1-AS1, and MAGI2-AS3, still remained in the co-expression network ([Figure 3C](#F3){ref-type="fig"}).

![Screening lncRNAs related to Lapatinib sensitivity. **(A)** The heatmap of 44 differentially expressed lncRNAs between high_IC50 group and low_IC50 groups (fold-change \>1.5, *P* \< 0.05). The red bars on the top present high_IC50 cases, and blue bars represent low_IC50 cases. The numbers of the right side are the names of lncRNAs. The numbers tagged in lncRNAs represent probe codes. **(B)** The co-expression molecular network of the 44 differentially expressed lncRNAs. The red ovals represent five crucial lncRNAs in the network, and the purple rectangles outside indicate the top 10 functional gene sets by GO analysis. **(C)** The co-expression molecular network of the top 50 differentially expressed genes and lncRNAs between the high_IC50 group and the low_IC50 group. In this network, three of differentially expressed molecules are lncRNAs (SPINT1-AS1, MAGI2-AS3, and GIHCG), which are underlined. The colors nodes of the network from red, dark yellow to light yellow indicate gradually weakened correlation to Lapatinib sensitivity.](fgene-10-00025-g0003){#F3}

###### 

Differentially expressed lncRNAs between Lapatinib high_IC50 and low_IC50 groups of 420 cancer cell lines (fold-change \>1.5, *P* \< 0.01).

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Probes**     **Title**                                                                  **Symbol**          **Ensemble transcript id version**   **Log FC**   ***P*-value**   **Adj. *P*-value**
  -------------- -------------------------------------------------------------------------- ------------------- ------------------------------------ ------------ --------------- --------------------
  225381_at      mir-100-let-7a-2 cluster host gene (non-protein coding)                    MIR100HG            ENSG00000255248.7                    1.339024     4.98E-08        1.48E-05

  226546_at      uncharacterized LOC100506844                                               GIHCG               ENSG00000257698.1                    1.19665      1.52E-15        8.13E-12

  228564_at      Long intergenic non-protein coding RNA 1116                                LINC01116           ENSG00000163364.9                    1.122804     4.24E-06        0.000493

  227554_at      MAGI2 antisense RNA 3                                                      MAGI2-AS3           ENSG00000234456.7                    1.096172     2.73E-07        5.84E-05

  1566482_at     NA                                                                         RP11-305O6.3        ENSG00000250280.2                    0.961776     3.96E-08        1.24E-05

  213156_at      Zinc finger and BTB domain containing 20                                   ZBTB20              ENSG00000259976.3                    0.942404     6.68E-06        0.000649

  213158_at      Zinc finger and BTB domain containing 20                                   ZBTB20              ENSG00000259976.3                    0.908785     1.6E-05         0.001179

  244741_s\_at   ZNF667 antisense RNA 1 (head to head)                                      ZNF667-AS1          ENSG00000166770.10                   0.873077     0.000703        0.019471

  229480_at      MAGI2 antisense RNA 3                                                      MAGI2-AS3           ENSG00000234456.7                    0.870971     4.07E-07        8.05E-05

  229493_at      HOXD cluster antisense RNA 2                                               HOXD-AS2            ENSG00000237380.6                    0.795366     2.89E-07        5.94E-05

  227082_at      Zinc finger and BTB domain containing 20                                   ZBTB20              ENSG00000259976.3                    0.780225     5.64E-05        0.003174

  226587_at      Prader Willi/Angelman region RNA 6                                         PWAR6               ENSG00000257151.1                    0.777959     0.0002          0.008638

  242358_at      RASSF8 antisense RNA 1                                                     RASSF8-AS1          ENSG00000246695.7                    0.770905     9.02E-08        2.29E-05

  236075_s\_at   Uncharacterized LOC101928000                                               LOC101928000        ENSG00000234327.7                    0.766575     6.6E-06         0.000649

  221974_at      Imprinted in Prader-Willi syndrome (non-protein coding) ///\               IPW ///\            ENSG00000224078.13                   0.719911     0.000535        0.016616
                 uncharacterized LOC101930404 ///\                                          LOC101930404 ///\                                                                     
                 Prader Willi/Angelman region RNA, SNRPN neighbor ///\                      PWARSN ///\                                                                           
                 small nucleolar RNA, C/D box 107 ///\                                      SNORD107 ///\                                                                         
                 small nucleolar RNA, C/D box 115--13 ///\                                  SNORD115-13 ///\                                                                      
                 small nucleolar RNA, C/D box 115--26 ///\                                  SNORD115-26 ///\                                                                      
                 small nucleolar RNA, C/D box 115--7 ///\                                   SNORD115-7 ///\                                                                       
                 small nucleolar RNA, C/D box 116--22 ///\                                  SNORD116-22 ///\                                                                      
                 small nucleolar RNA, C/D box 116--28 ///\                                  SNORD116-28 ///\                                                                      
                 small nucleolar RNA, C/D box 116--4 ///\                                   SNORD116-4 ///\                                                                       
                 small nuclear ribonucleoprotein polypeptide N                              SNRPN                                                                                 

  227099_s\_at   Chromosome 11 open reading frame 96                                        C11orf96            ENSG00000254409.2                    0.686826     0.001963        0.037596

  217520_x\_at   Uncharacterized LOC101929232 ///\                                          PDCD6IPP2           ENSG00000274253.4                    0.671638     1.03E-05        0.000862
                 PDCD6IP pseudogene 2                                                                                                                                             

  226591_at      Prader Willi/Angelman region RNA 6                                         PWAR6               ENSG00000257151.1                    0.665136     0.000597        0.018108

  233562_at      Long intergenic non-protein coding RNA 839                                 LINC00839           ENSG00000185904.11                   0.644287     0.000226        0.009558

  228370_at      Imprinted in Prader-Willi syndrome (non-protein coding) ///\               IPW ///\            ENSG00000224078.13                   0.63548      0.004004        0.056605
                 uncharacterized LOC101930404 ///\                                          LOC101930404 ///\                                                                     
                 Prader Willi/Angelman region RNA, SNRPN neighbor ///\                      PWARSN ///\                                                                           
                 small nucleolar RNA, C/D box 107 ///\                                      SNORD107 ///\                                                                         
                 small nucleolar RNA, C/D box 115--13 ///\                                  SNORD115-13 ///\                                                                      
                 small nucleolar RNA, C/D box 115--26 ///\                                  SNORD115-26 ///\                                                                      
                 small nucleolar RNA, C/D box 115--7 ///\                                   SNORD115-7 ///\                                                                       
                 small nucleolar RNA, C/D box 116--22 ///\                                  SNORD116-22 ///\                                                                      
                 small nucleolar RNA, C/D box 116--28 ///\                                  SNORD116-28 ///\                                                                      
                 small nucleolar RNA, C/D box 116--4                                        SNORD116-4                                                                            

  230272_at      Long intergenic non-protein coding RNA 461 ///\                            LINC00461 ///\      ENSG00000245526.10                   0.633241     0.000333        0.011874
                 microRNA 9-2                                                               MIR9-2                                                                                

  227121_at      Zinc finger and BTB domain containing 20                                   ZBTB20              ENSG00000259976.3                    0.622039     6.47E-05        0.003438

  228438_at      Uncharacterized LOC100132891                                               LOC100132891        ENSG00000235531.9                    0.610992     0.00111         0.026335

  213447_at      Imprinted in Prader-Willi syndrome (non-protein coding) ///\               IPW ///\            ENSG00000224078.13                   0.603999     0.000792        0.021388
                 uncharacterized LOC101930404 ///\                                          LOC101930404 ///\                                                                     
                 Prader Willi/Angelman region RNA, SNRPN neighbor ///\                      PWARSN ///\                                                                           
                 small nucleolar RNA, C/D box 107 ///\                                      SNORD107 ///\                                                                         
                 small nucleolar RNA, C/D box 115--13 ///\                                  SNORD115-13 ///\                                                                      
                 small nucleolar RNA, C/D box 115--26 ///\                                  SNORD115-26 ///\                                                                      
                 small nucleolar RNA, C/D box 115--7 ///\                                   SNORD115-7 ///\                                                                       
                 small nucleolar RNA, C/D box 116--22 ///\                                  SNORD116-22 ///\                                                                      
                 small nucleolar RNA, C/D box 116--28 ///\                                  SNORD116-28 ///\                                                                      
                 small nucleolar RNA, C/D box 116--4 ///\                                   SNORD116-4 ///\                                                                       
                 small nuclear ribonucleoprotein polypeptide N                              SNRPN                                                                                 

  238632_at      NA                                                                         RP11-44F21.5        ENSG00000260265.1                    −0.58771     0.000615        0.018108

  224646_x\_at   H19, imprinted maternally expressed transcript (non-protein coding) ///\   H19 ///\            ENSG00000130600.18                   −0.66521     0.008633        0.089285
                 microRNA 675                                                               MIR675                                                                                

  243729_at      NA                                                                         RP11-747H7.3        ENSG00000260711.2                    −0.68534     2.63E-09        1.08E-06

  1557779_at     Uncharacterized LOC101928687                                               LOC101928687        ENSG00000231131.6                    −0.69525     0.000133        0.006282

  229296_at      Uncharacterized LOC100506119                                               LOC100506119        ENSG00000233901.5                    −0.74915     3.12E-05        0.001938

  1557094_at     Uncharacterized LOC100996760                                               LOC100996760        ENSG00000276850.4                    −0.80357     4.07E-05        0.002362

  223779_at      AFAP1 antisense RNA 1                                                      AFAP1-AS1           ENSG00000272620.1                    −0.80513     6.36E-05        0.003434

  235921_at      Uncharacterized LOC102723721                                               LOC102723721        ENSG00000223784.1                    −0.81799     9.33E-06        0.000804

  1558216_at     AFAP1 antisense RNA 1                                                      AFAP1-AS1           ENSG00000272620.1                    −0.84595     0.000286        0.010641

  242874_at      NA                                                                         RP11-747H7.3        ENSG00000260711.2                    −0.92003     9.63E-11        6.43E-08

  227985_at      Uncharacterized LOC100506098                                               LOC100506098        ENSG00000233834.6                    −1.04243     7.5E-08         2E-05

  236279_at      NA                                                                         NA                  ENSG00000275234.1                    −1.04592     6.12E-10        2.97E-07

  232202_at      Family with sequence similarity 83, member B                               FAM83B              ENSG00000261116.1                    −1.07231     2.29E-10        1.22E-07

  238742_x\_at   Uncharacterized LOC102724362                                               SPINT1-AS1          ENSG00000261183.5                    −1.10252     6.38E-14        1.7E-10

  226755_at      MIR205 host gene (non-protein coding)                                      MIR205HG            ENSG00000230937.11                   −1.11922     1.11E-10        6.61E-08

  242354_at      NA                                                                         RP11-532F12.5       ENSG00000261183.5                    −1.19239     5.99E-13        8.01E-10

  229223_at      NA                                                                         RP11-96D1.11        ENSG00000262160.1                    −1.26926     1.78E-12        1.59E-09

  201510_at      E74-like factor 3 (ets domain transcription factor, epithelial-specific)   ELF3                ENSG00000249007.1                    −1.54591     1.36E-13        2.42E-10

  210827_s\_at   E74-like factor 3 (ets domain transcription factor, epithelial-specific)   ELF3                ENSG00000249007.1                    −1.63868     8.23E-13        8.79E-10

  227919_at      Urothelial cancer associated 1 (non-protein coding)                        UCA1                ENSG00000214049.7                    −1.65999     9.68E-08        2.35E-05
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*log FC, log2 of fold-change. Positive value indicates increased expression in high_IC50 group, and negative value indicates decreased expression in high_IC50 group. NA, Not available*.

Differential Expressing Analysis of Three LncRNAs Between Epithelial and Non-epithelial Cancer Groups
-----------------------------------------------------------------------------------------------------

We divided the 420 cancer cell lines into epithelium derived group (*n* = 278) and non-epithelium derived group (*n* = 142; including nervous system, bone, cartilage, and pleura). The differential expression levels of the three lncRNAs between the two groups are presented in [Figure 4A](#F4){ref-type="fig"}. In the epithelium-derived group, the differential expression levels of the three lncRNAs between Lapatinib high_IC50 and low_IC50 groups were significantly different ([Figure 4B](#F4){ref-type="fig"}, *P* \< 0.05). In the non-epithelium groups, there was no significant difference of the three lncRNAs between Lapatinib high_IC50 and low_IC50 groups. Higher expressing level of SPINT1-AS1 was found in epithelium-derived cancer cells, and higher expressing levels of MAGI2-AS3 and GIHCG were observed in the non-epithelium group.

![The correlation of expression levels of three crucial lncRNAs and originated sites of cancer cell lines. **(A)** The expression levels of GIHCG, SPINT1-AS1, and MAGI2-AS3 on 22 types of cancer cell lines. **(B)** The bar charts of expression levels of GIHCG, SPINT1-AS1, and MAGI2-AS3 between Lapatinib high_IC50 and low_IC50 groups in epithelial cancer cell lines and non-epithelial cancer cell lines.](fgene-10-00025-g0004){#F4}

Differentially expressed genes (1.5-fold change) between the Lapatinib high_IC50 and low_IC50 groups in epithelial group (Table S3) were utilized to perform GO analysis. Enhanced signatures of cell keratin, epithelial differentiation, and cell-cell junction were observed in Lapatinib low_IC50 group, and decreased signature of extracellular matrix were observed in Lapatinib low_IC50 group ([Figure 5](#F5){ref-type="fig"}, *P* \< 0.001, *P*. adjust \< 0.001).

![Pathway analysis of Lapatinib sensitivity related genes. The genes in the top 10 pathways with fold-change more than 1.5 are used between Lapatinib high_IC50 and low_IC50 groups. The middle brown dot of each network indicates the name of a gene set, and the small dots surrounding it indicate the genes of the gene set. The red dots represent the up-regulated genes in the high_IC50 group, and the green dots represent the up-regulated genes in the low_IC50 group. The darker red or green spot are the larger fold-change of differential genes. The black spots with different sizes and numbers on the right side indicate the gene numbers in the gene clusters.](fgene-10-00025-g0005){#F5}

Correlation of LncRNAs SPINT1-AS1, GIHCG, or MAGI2-AS3 and Lapatinib Sensitivity in Epithelial Group
----------------------------------------------------------------------------------------------------

Correlation analysis revealed that Lapatinib IC50 of the non-epithelial group was higher than that of the epithelial group ([Figure 6A](#F6){ref-type="fig"}). Of the three critical lncRNAs, SPINT1-AS1, and GIHCG were the lncRNAs most correlated to Lapatinib sensitivity ([Figure 6B](#F6){ref-type="fig"}). SPINT1-AS1 and GIHCG were selected as key factors of affecting Lapatinib sensitivity of epithelial cancers. The up-regulation of SPINT1-AS1 was found in low_IC50 group and increased GIHCG was found in high_IC50 group ([Figure 6C](#F6){ref-type="fig"}).

![Correlation analysis of three crucial lncRNAs GIHCG, SPINT1-AS1, MAGI2-AS3, and Lapatinib sensitivity in epithelial cancer cells. **(A)** Non-epithelial cancer cells showed higher Lapatinib_IC50 than epithelial cancer cells in the CCLE database. **(B)** Correlation between three lncRNAs and Lapatinib IC50 of epithelial cancer cells. Red circles represent negative correlation, and blue circles represent positive correlation. The number of the lower left grids indicates correlation coefficient between two factors (all *P*-values \< 0.001). **(C)** The heatmap presents expression levels of GIHCG and SPINT1-AS1 in Lapatinib high_IC50 and low_IC50 groups of epithelial cancer cell lines.](fgene-10-00025-g0006){#F6}

Validating Study of GIHCG and SPINT1-AS1 on Regulating Lapatinib Sensitivity *in vitro*
---------------------------------------------------------------------------------------

In validating experiments, we examined expression levels of GIHCG and SPINT1-AS1 in seven types of cancer cell lines (thyroid cancer, pancreatic cancer, liver cancer, melanoma, gastric cancer, breast cancer, and colorectal cancer) and Lapatinib IC50 of the same cancer cell lines. Correlation analysis showed that higher expression levels of SPINT1-AS1 were significantly associated with lower Lapatinib IC50 ([Figure 7A](#F7){ref-type="fig"}, *R* = −0.715, *P* \< 0.001), while higher expression levels of GIHCG were significantly related to higher Lapatinib IC50 ([Figure 7A](#F7){ref-type="fig"}, *R* = 0.557, *P* = 0.013).

![Validating study of lncRNAs GIHCG and SPINT1-AS1 on regulating Lapatinib sensitivity. **(A)** The Lapatinib IC50 and expression levels of GIHCG and SPINT1-AS1 are assayed on 19 cancer cell lines from different types of cancer origin. The expression level of GIHCG is positively related to Lapatinib IC50 (*R* = 0.557, *P* = 0.013), while the expression level of SPINT1-AS1 is negatively related to Lapatinib IC50 (*R* = −0.715, *P* \< 0.001). **(B)** Knockdown of GIHCG is performed by siRNA in BxPC3, MCF7, and NCIH-747 cancer cells. **(C)** Knockdown of SPINT1-AS1 is performed by siRNA in NCI-N87 and MCF7 cancer cells. **(D)** Knockdown of GIHCG shows enhancing Lapatinib sensitivity in BxPC3, MCF7, and NCIH-747 cancer cells. **(E)** Knockdown of SPINT1-AS1 shows promoting Lapatinib resistance in NCI-N87 and MCF7 cancer cells. **(F)** Knockdown of GIHCG discloses increased SPINT1-AS1 expression in BxPC3 and NCIH-747 cancer cells. **(G)** Knockdown of SPINT1-AS1 does not increase GIHCG expression in NCI-N87 and MCF7 cancer cells. Experimental group vs. negative control (NC), ^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01, ^\*\*\*^*P* \< 0.001.](fgene-10-00025-g0007){#F7}

The sensitive cancer cell lines of NCI-N87 (gastric cancer) and MCF7 (breast cancer), as well as the resistant cancer cell lines of NCIH-747(colon cancer) and BxPC3 (pancreatic cancer) were selected for a subsequent validating study. After knocking-down expression levels of GIHCG and SPINT1-AS1 by small interfering RNAs, Lapatinib IC50, and inhibitory rate of cancer cells were detected. Among three small interference sequences of GIHCG and SPINT1-AS1 mRNAs, siRNA sequence 3 of GIHCG (Si3, [Figure 7B](#F7){ref-type="fig"}), and siRNA sequence 1 of SPINT1-AS1 (Si1, [Figure 7C](#F7){ref-type="fig"}) were identified as effective siRNAs for further experiments.

Knocking-down of GIHCG could significantly enhance the sensitivity to Lapatinib in MCF7 and BxPC3 cancer cell lines ([Figure 7D](#F7){ref-type="fig"}), while down-regulation of SPINT1-AS1 could promote resistance to Lapatinib in NCI-N87 and MCF7 cancer cell lines ([Figure 7E](#F7){ref-type="fig"}). To clarify whether there is a mutual regulatory relationship between GIHCG and SPINT1-AS1, we detected the expression level of SPINT1-AS1 after GIHCG knockdown and vice versa. As shown in [Figures 7F](#F7){ref-type="fig"},**G**, suppression of GIHCG in Lapatinib resistant cancer cell lines NCIH-747 and BxPC3 could induce up-regulation of SPINT1-AS1 (*P* \< 0.05), while knockdown of SPINT1-AS1 did not change the expression level of GIHCG (*P* \> 0.05).

Discussion {#s4}
==========

LncRNA is an important regulatory molecule in drug resistance during chemotherapy or gene targeted therapy (Li et al., [@B20]; Dong et al., [@B8]; Wu et al., [@B41]; Zhou et al., [@B45]). In this study, we analyzed Lapatinib sensitivity to EGFR and ERBB2 targeted therapy pan-cancer cell line wide. We noticed that Lapatinib sensitivity was not only positively correlated to the activation of EGFR and ERBB2 signaling pathways, but also positively associated to cell keratin, epithelial differentiation, and cell-cell junction. The Lapatinib sensitivity of cancer cell lines was negatively associated to extracellular matrix signature. By screening differentially expressed lncRNAs and establishing co-expression network between Lapatinib high_IC50 and low_IC50 groups, three key lncRNAs, SPINT1-AS1, GIHCG, and MAGI2-AS3, were found. Of those, GIHCG and SPINT1-AS1 were only differentially expressed in epithelial derived cancers. SPINT1-AS1 was negatively related to Lapatinib IC50, whereas GIHCG was positively associated to Lapatinib IC50. By siRNAs treatment, downregulation of SPINTA-AS1 could promote Lapatinib resistance, while downregulation of GIHCG promoted Lapatinib sensitivity. The combination of bioinformatical approach and experimental study confirmed that lncRNAs were involved in regulating sensitivity to Lapatinib targeted therapy.

PI3K/Akt, Ras/Raf/MEK/ERK1/2, and PLCγ pathways are downstream pathways of EGFR and ERBB2 and play important roles in cell proliferation and survival of multiple cancers (Roskoski, [@B31]). The expression levels of EGFR and ERBB2 are positively correlated to Lapatinib sensitivity (Rusnak et al., [@B32]; Xiang et al., [@B42]). Trastuzumab (Herceptin) is a molecular targeted drug of ERBB2-positive metastatic/advanced breast cancer and gastric cancer (Bang et al., [@B2]; Loibl and Gianni, [@B23]). Lapatinib is a small molecule chemical, which proved effective for ERBB2-positive advanced or metastatic breast cancer when combined with capecitabine after previous treatment with anthracyclines, paclitaxel, or trastuzumab (Geyer et al., [@B9]). In gastric cancer, treatment with Lapatinib plus capecitabine and oxaliplatin also revealed anti-cancer effects on HER2-amplified gastroesophageal adenocarcinoma, especially in Asian and younger patients (Hecht et al., [@B13]). LncRNAs emerged as one of the new resistance mechanisms to chemotherapy or molecule targeted therapy. By bioinformatics analysis, Lapatinib sensitive cancer cells exhibited enrichment of genes related to cell keratin, epithelial differentiation, and cell-cell junction. The ERBB family plays an important role in regulating cell differentiation (Pellat et al., [@B27]). We noticed that Lapatinib sensitivity is positively correlated to ERBB pathway activation. It means that cancer cells sensitive to Lapatinib drug often showed enrichment of cell differentiation-related genes, while Lapatinib-resistant cancer cells are often accompanied by enrichment of extracellular matrix pathway (D\'Amato et al., [@B6]; Khan et al., [@B16]; Lin et al., [@B22]; Watson et al., [@B40]). Furthermore, increases of extracellular matrix could further induce epithelial-mesenchymal transition of cancer cells (Tzanakakis et al., [@B38]).

Although the role of lncRNAs in cancer progression and Lapatinib resistance have been reported in other studies (Russell et al., [@B33]; Li et al., [@B20]; Liang et al., [@B21]; Ma et al., [@B24]), this is the first study that proved that lncRNAs GIHCG and SPINT1-AS1 are involved in regulating therapeutic sensitivity to Lapatinib. Based on pan-cancer cell lines analysis, Lapatinib IC50 is significantly different between non-epithelial cancer cell lines, and epithelial cancer cell Lines. As the inhibitor of miR-200b/200a/429, LncRNA GIHCG was shown effectively promoting the progression of liver cancer through inducing methylation of miR-200b/200a/429 promoter (Sui et al., [@B36]). GIHCG is also involved in promoting cancer proliferation and migration in tongue and renal cancers (D\'Aniello et al., [@B7]; Ma et al., [@B24]). However, there is no study \$om whether or not GIHCG could regulate Lapatinib drug sensitivity in cancers. LncRNA SPINT1-AS1 is a Kunitz type 1 antisense RNA1, belonging to serine peptidase inhibitor. An increased expression of SPINT1-AS1 has been observed in colorectal cancer (Li C. et al., [@B18]). It is also the first time that lncRNA SPINT1-AS1 has been found regulating Lapatinib drug sensitivity on multiple cancer cells. In validating experiments, the knockdown of SPINT1-AS1 did not result in the up-regulation of GIHCG. We speculated that GIHCG may regulate SPINT1-AS1 expression through regulating promoter methylation or by manner of competitive endogenous RNA (ceRNA) (Zhang G. et al., [@B43]; Zhang L. et al., [@B44]). However, the mutual regulatory mechanisms of lncRNA GIHCG and SPINT1-AS1 remain to be studied in the future.

Conclusion {#s5}
==========

In conclusion, the current study proposed a group of lncRNAs related to Lapatinib sensitivity based on pan-cancer cell lines analysis. By subsequent experimental study, lncRNAs GIHCG and SPINT1-AS1 were firstly identified as crucial lncRNAs in regulating Lapatinib resistance or sensitivity in epithelium-derived cancer cell lines. SPINT1-AS1 is a Lapatinib sensitivity predictor, while GIHCG is a predictive molecule for Lapatinib resistance.
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